| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702589 | Urologic Oncology: Seminars and Original Investigations | 2017 | 8 Pages |
Abstract
Analysis of EuroTARGET cohort data will contribute to personalization of therapy for patients with mRCC. The extensive clinical data and multiplatform EuroTARGET data will be freely available.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Loes F.M. Ph.D., Sita H. Ph.D., Arna M.Sc., Jake S.F. M.Sc., Meta H.M. M.Pharm., Valentin M.D., Anne M.D., D.R., C.N.R.S., Daniel Castellano, Achim R.Ph., Jesus M.D., Ph.D., Rosa M.D., Henk-Jan Pharm.D., Ph.D., Arndt M.D., Christina M.D., Ph.D.,